Schedule 13G ownership disclosure
VERONA PHARMA PLC
Ordinary Shares, nominal value 0.05 GBP per share · CUSIP: 925050106
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Maverick Capital, Ltd.
Shares: 25,028,128 · Class: 3.8%
- Maverick Capital Management, LLC
Shares: 25,028,128 · Class: 3.8%
- Lee S. Ainslie III
Shares: 25,028,128 · Class: 3.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-021218
- Form type
- SCHEDULE 13G/A
- Filer
- MAVERICK CAPITAL LTD
- CIK
- CIK 934639
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership